8,847
Total Claims
$576K
Drug Cost
517
Beneficiaries
$1,115
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-27%
Cost per patient vs peers
$1,115 vs $1,524 avg
-21%
Brand preference vs peers
10.8% vs 13.7% avg
Brand vs Generic
89% generic
Brand: 955 claims · $472K
Generic: 7,892 claims · $104K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 204 | $120K |
| Sacubitril/Valsartan | 137 | $111K |
| Apixaban | 162 | $111K |
| Evolocumab | 70 | $40K |
| Ticagrelor | 65 | $35K |
| Empagliflozin | 30 | $21K |
| Metoprolol Succinate | 914 | $12K |
| Atorvastatin Calcium | 1,090 | $11K |
| Dapagliflozin Propanediol | 11 | $9,800 |
| Losartan Potassium | 703 | $8,764 |
| Levothyroxine Sodium | 101 | $5,140 |
| Chlorthalidone | 184 | $4,884 |
| Clopidogrel Bisulfate | 538 | $4,426 |
| Candesartan Cilexetil | 61 | $4,367 |
| Ezetimibe | 293 | $4,130 |
Prescribing Profile
62
Unique Drugs
$372K
Patient Profile
73
Avg Age
53%
Female
2.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data